Skattum Jorunn, Gaarder Christine, Naess Paal Aksel
Department of Traumatology, Oslo University Hospital Ullevaal, PO Box 4950, Nydalen, N-0424 Oslo, Norway.
Injury. 2014 Jan;45(1):160-3. doi: 10.1016/j.injury.2012.10.015. Epub 2012 Nov 5.
Non-operative management (NOM) is the treatment of choice in blunt splenic injuries in the paediatric population, with reported success rates exceeding 90%. Splenic artery embolisation (SAE) was added to our institutional treatment protocol for splenic injury in 2002. We wanted to review indications for SAE and the clinical outcome of splenic injury management in children admitted between August 1, 2002 and July 31, 2010.
Patients aged <17 years with splenic injury were identified in the institutional trauma and medical code registries. Patient charts and computed tomographic (CT) scans were reviewed.
Of the 72 children and adolescents with splenic injury included during the 8 year study period, 66 patients (92%) were treated non-operatively and six underwent operative management. Severe splenic injury (OIS grade 3-5) was diagnosed in 67 patients (93%). SAE was performed in 22 of the NOM patients. Indications for SAE included - bleeding (n=8), pseudoaneurysms (n=2), contrast extravasation (n=2), high OIS injury grade (n=8) and prophylactic due to specific disease (n=2). NOM was successful in all but one case (98%). For the patients aged ≤ 14 years, extravasation on initial CT scan correlated to delayed bleeding (p<0.001). Two SAE procedure specific complications were registered, but resolved without significant sequelae.
After SAE was added to the institutional treatment protocol, 22 of 66 NOM paediatric patients underwent SAE. NOM was successful in 98% and a 90% splenic preservation rate was achieved. Contrast extravasation correlated to delayed splenic bleeding in children ≤ 14 years.
非手术治疗(NOM)是小儿钝性脾损伤的首选治疗方法,报道的成功率超过90%。2002年,脾动脉栓塞术(SAE)被纳入我们机构的脾损伤治疗方案。我们想回顾2002年8月1日至2010年7月31日期间收治的儿童脾损伤患者的SAE适应证及脾损伤治疗的临床结果。
在机构创伤和医疗编码登记处识别年龄<17岁的脾损伤患者。查阅患者病历和计算机断层扫描(CT)图像。
在8年研究期间纳入的72例儿童和青少年脾损伤患者中,66例(92%)接受非手术治疗,6例接受手术治疗。67例(93%)诊断为严重脾损伤(器官损伤严重程度评分[OIS]3 - 5级)。22例非手术治疗患者接受了SAE。SAE的适应证包括出血(n = 8)、假性动脉瘤(n = 2)、造影剂外渗(n = 2)、高OIS损伤分级(n = 8)以及因特定疾病进行预防性治疗(n = 2)。除1例(98%)外,所有非手术治疗均成功。对于年龄≤14岁的患者,初始CT扫描时的造影剂外渗与延迟性出血相关(p<0.001)。记录到2例SAE手术相关并发症,但均未遗留明显后遗症而缓解。
在机构治疗方案中加入SAE后,66例接受非手术治疗的儿科患者中有22例接受了SAE。非手术治疗成功率为98%,脾保留率达90%。造影剂外渗与≤14岁儿童的延迟性脾出血相关。